Projects funded by the NCN
Iron chelators as tyrosine kinase inhibitors - a new strategy for the treatment of glioblastoma multiforme
2020/39/O/NZ5/02342
Keywords:
glioblastoma multiforme iron chelator tyrosine kinase inhibitor blood-brain barrier
Descriptors:
- NZ5_7: Human disease treatment
- NZ3_5: Molecular neurobiology
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Śląski w Katowicach, Wydział Nauk Ścisłych i Technicznych
woj. śląskie
Principal investigator (from the host institution):
dr hab. Anna Mrozek-Wilczkiewicz
Number of co-investigators in the project: 2
Call: PRELUDIUM BIS 2 - announced on 2020-09-15
Amount awarded: 541 680 PLN
Project start date (Y-m-d): 2021-07-12
Project end date (Y-m-d): 2025-09-30
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.